Overview Rating

Good

Technicals Analysis

100

0100

Financials Analysis

0100

Dr Reddy's Laboratories (NYSE:RDY) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Dr Reddy's Laboratories (RDY) operate in?

Dr Reddy's Laboratories is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.

Dr Reddy's Laboratories Stock (NYSE: RDY) stock price, news, charts, stock research, profile.

Open	$15.71
Close	$15.81
Volume / Avg.	1.25M / 1.20M
Day Range	$15.63 - $15.82
52 Wk Range	13.43 - 16.89
Market Cap	$13.17B
P/E Ratio	20.48
Dividend Yield	0.60%
Exchange	NYSE
RSI	62
Short Interest	1.77%
Days to Cover	7.36

Recent News

CVS Health's Aetna Files Lawsuit Against Drugmakers For Alleged Inflated Generic Drug Prices

CVS' Aetna sues drug manufacturers for price-fixing and market allocation scheme. The subsidiary seeks damages and injunctions.

Vandana Singh

Teva Pharmaceutical, Li Auto, And Darden Restaurants Are Among Top Large Cap Gainers Last Week (December 16-20): Are The Others In Your Portfolio?

The top-performing stocks last week were TEVA, KVYO, DRI, DOCS, BIRK, JBL, NBIX, GME, RDY, and LI. Did you have any of them in your portfolio?

Lekha Gupta

Dr. Reddy's Lab Delivers 'Another Good Quarter,' CEO Says As Revenue Jumps 17%

Dr. Reddy's Q2 2025 report shows a revenue boost to $957 million, fueled by global generics. North American sales rose 17% year-over-year.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jul 24

Nov 24

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.5

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$15.71
Close	$15.81
Volume / Avg.	1.25M / 1.20M
Day Range	$15.63 - $15.82
52 Wk Range	13.43 - 16.89
Market Cap	$13.17B
P/E Ratio	20.48
Dividend Yield	0.60%
Exchange	NYSE
RSI	62
Short Interest	1.77%
Days to Cover	7.36

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy Dr Reddy's Laboratories (RDY) stock?

You can purchase shares of Dr Reddy's Laboratories (NYSE:RDY) through any online brokerage.

View our list of the best stock brokerages

Who are Dr Reddy's Laboratories (RDY) competitors?

Other companies in Dr Reddy's Laboratories’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Verona Pharma (NASDAQ:VRNA) and Novartis (NYSE:NVS).

What is the forecast, or price target, for Dr Reddy's Laboratories (RDY) stock?

Dr Reddy's Laboratories has a consensus price target of $17.00.

What is the current price for Dr Reddy's Laboratories (RDY)?

The stock price for Dr Reddy's Laboratories (NYSE: RDY) is $15.81 last updated January 8, 2025 at 4:00 PM EST.

Does Dr Reddy's Laboratories (RDY) pay a dividend?

A quarterly cash dividend of 0.48 per share of Class A Common Stock. The quarterly cash dividend was payable on August 12, 2024 to stockholders of record on July 15, 2024.

When is Dr Reddy's Laboratories (NYSE:RDY) reporting earnings?

Dr Reddy's Laboratories’s Q3 earnings are confirmed for Tuesday, January 28, 2025.

Is Dr Reddy's Laboratories (RDY) going to split?

There is no upcoming split for Dr Reddy's Laboratories.

What sector and industry does Dr Reddy's Laboratories (RDY) operate in?

Dr Reddy's Laboratories is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.

Comments

Dr Reddy's Laboratories

Dr Reddy's Laboratories (RDY) Forecast